The release of the snapshot containing the respective simulations can be found here:
https://github.com/Open-Systems-Pharmacology/Erythromycin-Triazolam-DDI/releases/tag/v1.2

The erythromycin-triazolam interaction was evaluated using two clinical DDI studies ([Greenblatt 1998](#4-references), [Phillips 1986](#4-references)).



| DataID | Enzyme | Perpetrator / victim     | Study design                                                 | Clinical study                   |
| ------ | ------ | ------------------------ | ------------------------------------------------------------ | -------------------------------- |
| 781    | CYP3A4 | Erythromycin / triazolam | Erythromycin: 500 mg po twice daily for 2 days<br />Triazolam: 0.125 mg po single dose, 1 hour after the 3<sup>rd</sup> erythromycin dose | [Greenblatt 1998](#4-references) |
| 757    | CYP3A4 | Erythromycin / triazolam | Erythromycin: 333 mg po TID for 3 days<br />Triazolam: 0.5 mg po single dose, together with the last erythromycin dose | [Phillips 1986](#4-references)   |


